Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tommy F Liu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|September 2, 2009
Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutationsRajin Shahriar, Soo-Yon Rhee, Tommy F Liu, et al.
Antiviral Research|September 30, 2010
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discoverySoo-Yon Rhee, Severine Margeridon-Thermet, Mindie H Nguyen, et al.
Plos One|July 11, 2013
Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment RegimensGert U Van Zyl, Tommy F Liu, Mathilda Claassen, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2013
Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1Vici Varghese, Yumi Mitsuya, W Jeffrey Fessel, et al.
Journal of Virology|August 22, 2008
Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutationsYumi Mitsuya, Vici Varghese, Chunlin Wang, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2012
Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatmentSeverine Margeridon-Thermet, Evguenia S Svarovskaia, Farbod Babrzadeh, et al.
Journal of Clinical Microbiology|March 10, 2012
Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis toolConan K Woods, Chanson J Brumme, Tommy F Liu, et al.
AIDS Research and Therapy|May 5, 2012
Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodesSoo-Yon Rhee, Jose Luis Blanco, Tommy F Liu, et al.
The Journal of Infectious Diseases|June 26, 2009
Predictive value of HIV-1 genotypic resistance test interpretation algorithmsSoo-Yon Rhee, W Jeffrey Fessel, Tommy F Liu, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2013
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testingGeorge L Melikian, Soo-Yon Rhee, Vici Varghese, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|September 2, 2009
Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutationsRajin Shahriar, Soo-Yon Rhee, Tommy F Liu, et al.
Antiviral Research|September 30, 2010
Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discoverySoo-Yon Rhee, Severine Margeridon-Thermet, Mindie H Nguyen, et al.
Plos One|July 11, 2013
Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment RegimensGert U Van Zyl, Tommy F Liu, Mathilda Claassen, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2013
Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1Vici Varghese, Yumi Mitsuya, W Jeffrey Fessel, et al.
Journal of Virology|August 22, 2008
Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutationsYumi Mitsuya, Vici Varghese, Chunlin Wang, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2012
Low-level persistence of drug resistance mutations in hepatitis B virus-infected subjects with a past history of Lamivudine treatmentSeverine Margeridon-Thermet, Evguenia S Svarovskaia, Farbod Babrzadeh, et al.
Journal of Clinical Microbiology|March 10, 2012
Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis toolConan K Woods, Chanson J Brumme, Tommy F Liu, et al.
AIDS Research and Therapy|May 5, 2012
Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodesSoo-Yon Rhee, Jose Luis Blanco, Tommy F Liu, et al.
The Journal of Infectious Diseases|June 26, 2009
Predictive value of HIV-1 genotypic resistance test interpretation algorithmsSoo-Yon Rhee, W Jeffrey Fessel, Tommy F Liu, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2013
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testingGeorge L Melikian, Soo-Yon Rhee, Vici Varghese, et al.
Pageof 3